U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07345390) titled 'Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris' on Dec. 25, 2025.
Brief Summary: This study will evaluate the safety, efficacy and pharmacokinetics of KR230109 cream compared with placebo in Patients (18-40 Years) with Acne vulgaris
Study Start Date: Jan. 10
Study Type: INTERVENTIONAL
Condition:
Acne Vulgaris
Intervention:
DRUG: KR230109 cream 0.025%
KR230109 cream 0.025% is indicated for the topical treatment of acne vulgaris in patients
DRUG: KR230109 cream 0.05%
KR230109 cream 0.05% is indicated for the topical treatment of acne vulgaris in patients
DRUG: Placebo
Vehicle ...